NSC |
Compound |
Enrichment |
Correlation |
NSC 690972 |
Null |
0.0267520285931239 |
-0.1717296 |
NSC 707054 |
Null |
0.0267520285931239 |
-0.21510323 |
NSC 708046 |
Null |
0.0267520285931239 |
-0.0077596997 |
NSC 708048 |
2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- |
0.0267520285931239 |
0.017010078 |
NSC 709362 |
Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- |
0.0267520285931239 |
0.0097947746 |
NSC 714636 |
Null |
0.0267520285931239 |
-0.14304543 |
NSC 727286 |
6-(bromomethyl)-1,4-anthracenedione. |
0.0267520285931239 |
-0.06520216 |
NSC 76150 |
Null |
0.0267520285931239 |
0.25712202 |
NSC 267461 |
Nanaomycin |
0.027843564133142 |
-0.1896713 |
NSC 641052 |
Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) |
0.027843564133142 |
-0.038848242 |